In the context of the forthcoming election, the fiscal deficit dominates the political discourse, writes Deutsche Bank's Paul Wharton
Alliance Bernstein's Martin Reeves on the strong performance of the euro high-yield market.
Despite the recent woes in the economic environment, the default risk of European structured finance securities and their ratings has so far been largely unaffected, writes S&P's Andrew South.
Asian convertibles may not be a traditional option for UK investors but they could be the best way to play Asia in the likely volatile markets of 2010, writes Kurt Fisch
Investors should remember the advantages listed hedge funds have over traditional hedge funds, says Edward Cartwright of LGT Capital Partners
Janus Capital's Gibson Smith on why corporate credit now plays a critical role in generating superior risk-adjusted outperformance.
Standard & Poor's Andrew South on European structured finance downgrades
Reform of the US healthcare system is a high priority for President Obama's new Democrat administration. The biotech sector is coming of age, and is poised to benefit by supplying the innovation required